摘要 |
Peptide reagents that interact preferentially with the PrP<SUP>sc </SUP>form of the prion protein are described. Methods of using the reagents or antibodies to the reagents for detection, diagnosis, purification, therapy and prophylaxis for prions and prion-associated diseases are also described. |